Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 08.12.2020.

#PROGENITY
#Biotech
#Kinnate
#IPOs
#prorata

Startups

@ksbosley shared
On Dec 4, 2020
RT @matthewherper: A health care investor on the wild ride of 2020 and what to expect in 2021 https://t.co/PB2214Xnfr
Open
A longtime health care investor on the wild ride of 2020 and what to expect in 2021

A longtime health care investor on the wild ride of 2020 and what to expect in 2021

Adam Koppel, co-founder of Bain Capital Life Sciences, joined STAT to talk about what to expect in science and in investing.

@zbiotech shared
On Dec 3, 2020
Senator David Perdue, a Georgia Republican, has been the Senate’s most prolific stock trader during his time in office — by himself accounting for nearly one-third of all transactions by senators in the past six years. https://t.co/phdQh7yjeu
Open
2,596 Trades in One Term: Inside Senator Perdue’s Stock Portfolio

2,596 Trades in One Term: Inside Senator Perdue’s Stock Portfolio

The Georgia Republican’s stock trades have far outpaced those of his Senate colleagues and have included a range of companies within his Senate committees’ oversight, an analysis shows.

@WSJVC shared
On Dec 3, 2020
Firms such as Khosla Ventures and Andreessen Horowitz are investing in anti-aging biotech startups https://t.co/aZifkfw7lz
Open
Venture Capitalists Back Biotech Push to Combat Aging

Venture Capitalists Back Biotech Push to Combat Aging

Khosla Ventures is leading a $12 million seed financing for Rubedo Life Sciences Inc., while Andreessen Horowitz and entrepreneur Elad Gil are leading a $90 million investment in BioAge ...

@big4bio shared
On Dec 4, 2020
#Biotech companies raised big money this week! #IPOs $SGTX $SEER $KNTE $PROG $CERT @Sigilon_Inc @seer_bio #Kinnate #PROGENITY @Certara https://t.co/aAZ9imyiU0
Open
Four Biotechs Roar with Strong IPOs, Other Life Sciences Companies Raise Additional Funds

Four Biotechs Roar with Strong IPOs, Other Life Sciences Companies Raise Additional Funds

Like the Grinch’s heart at Christmas, the Nasdaq Exchange grew a little bigger this week with multiple life science companies raising hundreds of millions of dollars in initial public ...

@BiotechWorld shared
On Dec 1, 2020
Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer https://t.co/3jCnUqevVb https://t.co/nVJ71hpvC8
Open
Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer

Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer

A host of top-suite venture capitalist firms have helped put together a meaty series A for an immuno-oncology biotech 2.0.

@BentheFidler shared
On Dec 7, 2020
Bayer strikes a deal with Atara, wading deeper into cell therapy https://t.co/iBh1rawOjn $ATRA + 6% $BAYRY
Open
Bayer strikes a deal with Atara, wading deeper into cell therapy

Bayer strikes a deal with Atara, wading deeper into cell therapy

A pact for two Atara programs continues the German pharma's efforts to use dealmaking to build a gene and cell therapy division.

@bryce shared
On Dec 3, 2020
“Any "smart money" that pulled back looks dumb, while plenty of dumb money looks prophetic” https://t.co/0w3XeG7h1d #prorata
Open
Top of the Morning

Top of the Morning

http://axios.link/k1eg 🚑 Everlywell, an Austin, Texas-based in-home health testing platform, raised $175 million in Series D funding from BlackRock, TCG, Foresite Capital, …

@BiotechWorld shared
On Dec 7, 2020
After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara https://t.co/DNBN9SvwAz https://t.co/c4aGvhUSWY
Open
After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara

After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara

German pharma Bayer is moving into cell therapy R&D with its latest pact focusing on tough-to-treat lung cancers with Atara Biotherapeutics.

Read more: Startups
weekly 08.12.2020
View archives
Back to home